Cours Parnell Pharmaceuticals Holdings Ltd Other OTC
Actions
PARNF
AU0000XINEU9
Produits pharmaceutiques
CA 2020 | 30 M 20,03 M 18,42 M | CA 2021 | 34,17 M 22,81 M 20,98 M | Capitalisation | 4,08 k 2,73 k 2,51 k |
---|---|---|---|---|---|
Résultat net 2020 | -15 M -10,01 M -9,21 M | Résultat net 2021 | -1 M -668 k -614 k | VE / CA 2020 | 2,18 x |
Dette nette 2020 | 56,16 M 37,49 M 34,48 M | Dette nette 2021 | 58,89 M 39,32 M 36,16 M | VE / CA 2021 | 1,72 x |
PER 2020 |
-0,56
x | PER 2021 |
-
| Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 100 % |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/02/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/12/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
-12,21 % | 79,07 Md | |
+25,25 % | 3,72 Md | |
+1,39 % | 3,33 Md | |
+16,55 % | 1,71 Md | |
-8,73 % | 1,52 Md | |
-23,19 % | 1,29 Md | |
-3,22 % | 1,29 Md | |
-12,66 % | 1,15 Md | |
+0,24 % | 1,05 Md |